Revisión datos de PANITUMUMAB en función de la localización del tumor - page 41

CRYSTAL
FIRE 3
CLAGB
80405
PRIME
PEAK
TAULI
SLP IZDO
NO AC
ANTIEGFR
Beva
P:0.0001
HR:0.50
8.9m
12.0m
P:0.38
HR:0.90
10.7m
10.7m
P:0.15
HR:0.84
12.7m
11.2m
P:
HR:0.72
9.2m
12.9m
P:
HR:0.65
14.6m
11.5m
P:0.011
HR:
9.0m
15.0m
14.0m
SG IZDO
NO AC
ANTIEGFR
Beva
P:0.002
HR:0.65
21.7m
28.7m
P:0.002
HR:0.63
38.3m
28.0m
P:0.04
HR:0.77
39.3m
32.6m
P:
HR:0.73
23.6m
30.3m
P:
HR:0.84
43.4m
32.0m
P:
HR:
27.0m
28.0m
32.0m
Comparativo estudios: Colon Izquierdo
1...,31,32,33,34,35,36,37,38,39,40 42
Powered by FlippingBook